Tag Archives: GCGMF

Hot Undervalued Stocks For 2019

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-928036638&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/928036638/960×0.jpg?fit=scale&q; data-height=&q;645&q; data-width=&q;960&q;&g; Abstract network connection pattern over city skyline

Despite the micro-bubble in &l;a href=&q;https://www.newconstructs.com/bursting-the-micro-bubble-part-1/&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;specific tech stocks&l;/a&g;, investors can still find value in the sector. This tech firm has a long history of profit growth, prudent capital stewardship, and an undervalued stock. It&a;rsquo;s business model creates more value than peers. Add in its position in multiple fast-growing markets and its clear why Insight Enterprises (NSIT) is this week&a;rsquo;s &l;a href=&q;https://www.newconstructs.com/category/stock-plays-of-the-week/&q; target=&q;_blank&q; rel=&q;noopener noreferrer&q; target=&q;_blank&q;&g;Long Idea&l;/a&g;.

Hot Undervalued Stocks For 2019: Great Canadian Gaming Corporation (GCGMF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Clairvest Group previously initiated an investment in a partnership that involved Great Canadian Gaming Corporation (OTCPK:GCGMF) and Brookfield Business Partners LP to operate two casinos in Southern Ontario. With this announcement, we not only get the upside of a 45% ownership of “Ontario Gaming West GLA Limited Partnership,” which includes four major operations, but also 2,500 slot machines, 60 table games, racing track and $450 million in gross gaming revenue. Clairvest has a history in the gambling industry and Great Canadian Gaming Corporation is a proven operator with a terrific track record.

Hot Undervalued Stocks For 2019: Synnex Corporation(SNX)

Advisors’ Opinion:

  • [By Max Byerly]

    Synnex (NYSE: SNX) and Presidio (NASDAQ:PSDO) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

  • [By Ethan Ryder]

    Cross Research lowered shares of SYNNEX (NYSE:SNX) from a buy rating to a hold rating in a report released on Friday morning.

    Other research analysts have also recently issued research reports about the stock. Stifel Nicolaus reduced their price target on shares of SYNNEX from $140.00 to $130.00 and set a buy rating for the company in a report on Friday. Pivotal Research reduced their price target on shares of SYNNEX from $135.00 to $130.00 and set a buy rating for the company in a report on Friday. Needham & Company LLC reiterated a buy rating and issued a $135.00 price target (down previously from $151.00) on shares of SYNNEX in a report on Monday, April 2nd. They noted that the move was a valuation call. Zacks Investment Research upgraded shares of SYNNEX from a sell rating to a hold rating in a report on Tuesday, June 5th. Finally, ValuEngine cut shares of SYNNEX from a hold rating to a sell rating in a report on Wednesday, May 2nd. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. The stock has a consensus rating of Hold and a consensus target price of $141.14.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on SYNNEX (SNX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Undervalued Stocks For 2019: Teva Pharmaceutical Industries Limited(TEVA)

Advisors’ Opinion:

  • [By Chris Lange]

    Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) short interest decreased to 47.70 million from the previous level of 49.03 million. Shares were trading at $23.86, in a 52-week range of $10.85 to $33.82.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    As for weaker generic-drug pricing, this isn’t anything new. Generic drugmakers like Teva Pharmaceutical Industries (NYSE:TEVA) have been pressured by weaker generic drug prices since the third quarter of last year. However, weakness in pricing has recently shown signs of stabilizing. Generic drug manufacturers and Wall Street analysts both seem to believe that 2019 will offer much-needed price stabilization for generic therapies. Considering that generics make up the bulk of total written prescription — about nine out of 10 — it seems only logical that pricing power will return to generic drugmakers and distributors sooner rather than later.

  • [By Jon C. Ogg]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) was raised to Outperform from Market Perform with a $22 target price (versus a $17.63 close) at Raymond James.

  • [By Chris Lange]

    24/7 Wall St. had previously reported that Teva Pharmaceutical Ltd. (NYSE: TEVA) is entering the generic EpiPen business, and this could potentially lead to a price war with Mylan.

  • [By Shane Hupp]

    Jafra Capital Management LP purchased a new stake in Teva Pharmaceutical Industries Ltd (NYSE:TEVA) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 315,000 shares of the company’s stock, valued at approximately $7,661,000. Teva Pharmaceutical Industries accounts for 2.7% of Jafra Capital Management LP’s portfolio, making the stock its 5th largest position.

  • [By Dan Caplinger]

    Wednesday was a relatively calm day on Wall Street until the last few minutes of the trading session, as major market benchmarks didn’t initially respond in dramatic fashion to much-anticipated news on the interest rate front. As expected, monetary policy from the Federal Reserve remained consistent with the trajectory the central bank has followed for more than a year, and the target on short-term rates climbed by a quarter point to a new range of between 2% and 2.25%. That’s good news for savers, but investors seemed to see mixed implications for companies in different sectors, and a late-day sell-off sent the Dow Jones Industrial Average down more than 100 points. Some stocks also responded negatively to more specific news affecting their businesses. Southwestern Energy (NYSE:SWN), Teva Pharmaceutical Industries (NYSE:TEVA), and Chegg (NYSE:CHGG) were among the worst performers on the day. Here’s why they did so poorly.

Hot Undervalued Stocks For 2019: FS Bancorp, Inc.(FSBW)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on FS Bancorp (FSBW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on FS Bancorp (FSBW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on FS Bancorp (FSBW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Undervalued Stocks For 2019: TransAlta Corporation(TAC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Shares of TransAlta (TSE:TA) (NYSE:TAC) have been given a consensus rating of “Hold” by the eight brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company. The average 12-month target price among analysts that have covered the stock in the last year is C$8.25.

  • [By Max Byerly]

    TransAlta (NYSE: TAC) and CLP (OTCMKTS:CLPHY) are both utilities companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, earnings, dividends and profitability.

  • [By Ethan Ryder]

    TransAlta (NYSE: TAC) and Enel S.p.A. ADS Common Stock (OTCMKTS:ENLAY) are both utilities companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, dividends, risk, analyst recommendations, earnings and valuation.

Top Performing Stocks To Watch For 2019

The business model that felled what was once the world’s biggest renewable energy company is alive and making money in Britain.

Listed funds using the yieldco model are outperforming the FTSE All-Share Index on a risk-adjusted return basis, according to research from Imperial College.

“Yieldco” had almost become a dirty word after SunEdison Inc.’s bankruptcy in 2016. The strategy involves listing a fund on a stock exchange and using the capital raised to buy operating solar and wind farms. Cash from electricity sales is paid out to shareholders as dividends.

Britain On Top

U.K. yieldcos are beating stock indexes on risk-adjusted returns

Source: Imperial College's Center for Climate Finance & Investment

.chart-js { display: none; }

Both the U.S. and the U.K. “embarked down this green infrastructure path at the exact same time with the exact same idea. But here’s the rub, the U.S. blew it,” said Charles Donovan, director for Imperial College’s Center for Climate Finance and Investment. “There has just been too aggressive an approach to structuring in the U.S. and performance has suffered as a result.”

Top Performing Stocks To Watch For 2019: China Digital TV Holding Co., Ltd.(STV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Sativacoin (CURRENCY:STV) traded 2.1% higher against the US dollar during the 1-day period ending at 22:00 PM E.T. on May 9th. Over the last week, Sativacoin has traded up 0.1% against the US dollar. One Sativacoin coin can now be purchased for $0.0318 or 0.00000341 BTC on popular exchanges including Cryptopia and YoBit. Sativacoin has a market capitalization of $225,415.00 and $19.00 worth of Sativacoin was traded on exchanges in the last 24 hours.

Top Performing Stocks To Watch For 2019: Great Canadian Gaming Corporation (GCGMF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Clairvest Group previously initiated an investment in a partnership that involved Great Canadian Gaming Corporation (OTCPK:GCGMF) and Brookfield Business Partners LP to operate two casinos in Southern Ontario. With this announcement, we not only get the upside of a 45% ownership of “Ontario Gaming West GLA Limited Partnership,” which includes four major operations, but also 2,500 slot machines, 60 table games, racing track and $450 million in gross gaming revenue. Clairvest has a history in the gambling industry and Great Canadian Gaming Corporation is a proven operator with a terrific track record.

Top Performing Stocks To Watch For 2019: Critical Elements Corporation (CRECF)

Advisors’ Opinion:

  • [By ]

    Other juniors include: Advantage Lithium (OTCQB:AVLIF) [TSXV:AAL], AIS Resources [TSXV:AIS] (OTCQB:AISSF), American Lithium Corp. [TSX-V: LI] (OTCQB:LIACF), Argentina Lithium and Energy Corp. [TSXV:LIT] (OTCQB:PNXLF), Argosy Minerals [ASX:AGY] (OTC:ARYMF), AVZ Minerals [ASX:AVZ] (OTC:AZZVF), Bacanora Minerals [TSXV:BCN] [AIM:BCN] [GR:1BQ] (OTC:BCRMF), Birimian Ltd [ASX:BGS] (OTC:EEYMF), Critical Elements [TSXV:CRE] [GR:F12] (OTCQX:CRECF), Dajin Resources [TSXV:DJI] (OTCPK:DJIFF), Enigri (private), Eramet (EN Paris:ERA) (OTCPK:ERMAY), European Metals Holdings [ASX:EMH] [AIM:EMH] [GR:E861] (OTC:ERPNF), Far Resources [CSE:FAT] (OTCPK:FRRSF), Force Commodities [ASX:4CE], Kidman Resources [ASX:KDR] [GR:6KR], Latin Resources Ltd [ASX: LRS] (OTC:LAXXF), Lithium Australia [ASX:LIT] (OTC:LMMFF), Lithium Power International [ASX:LPI] (OTC:LTHHF), LSC Lithium [TSXV:LSC] (OTC:LSSCF), MetalsTech [ASX:MTC], MGX Minerals [CSE:XMG] (OTC:MGXMF), Millennial Lithium Corp. [TSXV:ML] (OTCQB:MLNLF), Neo Lithium [TSXV:NLC] (OTC:NTTHF), NRG Metals Inc. [TSXV:NGZ] (OTCQB:NRGMF), Nemaska Lithium [TSX:NMX] [GR:NOT] (OTCQX:NMKEF), North American Lithium (private), Piedmont Lithium [ASX:PLL] (OTC:PLLLY), Prospect Resources [ASX:PSC], Sayona Mining [ASX:SYA] (OTCPK:DMNXF), Savannah Resources [LSE:SAV], Standard Lithium [TSXV:SLL] (OTC:STLHF), and Wealth Minerals [TSXV:WML] (OTCQB:WMLLF).

  • [By ]

    The following 6 companies are on the bench for the index:

    Advantage Lithium (OTCQX:AVLIF) Argosy Minerals (OTCPK:ARYMF) Bacanora Minerals (OTC:BCRMF) Critical Elements (OTCQX:CRECF) NEO Lithium (OTCQX:NTTHF) Wealth Minerals (OTCQX:WMLLF)

    “Bench” is a sports analogy meaning that one or more of them could be added in the future if one of the above companies becomes a producer, is acquired, or the market capitalization (“cap”) of one or more of the index holdings falls significantly below that of one or more companies on the bench.

Top Blue Chip Stocks To Invest In 2018

At first, the gifts seemed innocent enough: a free dinner and a private helicopter tour over the Grand Canyon. By the end of it, though, the Polish official was standing in a Warsaw parking lot, accepting $100,000 in bags of cash, given to him in exchange for multi-million-dollar government contracts.

You might be thinking that this government employee was being paid off by the mafia or some shadowy military contractor, but think again: According to the SEC and Polish prosecutors, the official was allegedly bribed by white-collar executives within Hewlett Packard (NYSE:HPQ) and IBM (NYSE:IBM), the American blue chip technology firms.

In 2014, the SEC charged HP with violating the Foreign Corrupt Practices Act in Poland. At the time, the agency explained HP executives “provided gifts and cash bribes worth more than $600,000 to a Polish government official to obtain contracts with the national police agency.”

Click to enlarge

Top Blue Chip Stocks To Invest In 2018: Methanex Corporation(MEOH)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Advisors Preferred LLC bought a new stake in shares of Methanex (NASDAQ:MEOH) (TSE:MX) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,703 shares of the specialty chemicals company’s stock, valued at approximately $103,000.

  • [By VantagePoint]

    Methanex Corporation (NASDAQ: MEOH) has experienced some recent weakness, but according to the chart below the stock is still in a clear uptrend. Since experiencing a bullish crossover on March 16 following some consolidation, the stock is up 20 percent. Look out for its next earnings report on April 26. 

Top Blue Chip Stocks To Invest In 2018: Great Canadian Gaming Corporation (GCGMF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Clairvest Group previously initiated an investment in a partnership that involved Great Canadian Gaming Corporation (OTCPK:GCGMF) and Brookfield Business Partners LP to operate two casinos in Southern Ontario. With this announcement, we not only get the upside of a 45% ownership of “Ontario Gaming West GLA Limited Partnership,” which includes four major operations, but also 2,500 slot machines, 60 table games, racing track and $450 million in gross gaming revenue. Clairvest has a history in the gambling industry and Great Canadian Gaming Corporation is a proven operator with a terrific track record.

Top Blue Chip Stocks To Invest In 2018: Stantec Inc(STN)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million.
    AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million.
    Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion.
    Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion.
    Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion.
    Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion.
    Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million.
    Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million.
    ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million.
    Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion.
    Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion.
    Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion.
    NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million.
    World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million.
    MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million.
    Choice Hotels International, Inc. (NYSE: CH
  • [By Logan Wallace]

    Stantec (TSE:STN) (NYSE:STN) has received a consensus rating of “Buy” from the nine research firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is C$36.50.

Top 10 Clean Energy Stocks To Own Right Now

One of the richest men in China has made a big bet on an icon of Europe’s automotive industry.

Li Shufu, the billionaire chairman of Chinese car maker Geely (GELYF), invested about $9 billion buying a stake of almost 10% in Daimler (DDAIF), making him the biggest single shareholder in the owner of Mercedes Benz.

Li, who’s estimated to be worth around $18 billion, has said he’s not interested in a takeover of Daimler. It’s unclear exactly what he’s after with such a big investment, but he dropped a big hint that the German company’s engineering is central to his vision.

“In order to succeed and seize the technology highland, one has to have friends, partners, and alliances and adapt a new way of thinking in terms of sharing and united strength,” Li said in a statement over the weekend.

Some analysts suggest Li wants to get his hands on Daimler’s clean energy technology. That could help boost Geely’s competitive position in China’s market for electric vehicles, which is already the world’s biggest.

Top 10 Clean Energy Stocks To Own Right Now: Keryx Biopharmaceuticals, Inc.(KERX)

Advisors’ Opinion:

  • [By Keith Speights]

    There were definitely some good parts in what Keryx Biopharmaceuticals (NASDAQ: KERX  ) had to say at this week’s Stifel Nicolaus Weisel Healthcare Conference in Boston. A lot was said, but here are the three highlights you’ll want to know about.

  • [By Lisa Levin]

    Thursday afternoon, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Amicus Therapeutics, Inc. (NASDAQ: FOLD).

  • [By Lisa Levin]

    Keryx Biopharmaceuticals (NASDAQ: KERX) shares shot up 14 percent to $5.17 after the company announced positive top-line results from its pivotal Phase 3 study of ferric citrate for the treatment of iron deficiency anemia in adults with non-dialysis dependent chronic kidney disease.

  • [By Lisa Levin]

    Thursday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI).

  • [By Maxx Chatsko]

    While companies with lower-priced shares are often riskier than those with higher prices, some companies trading under $5 per share have intriguing potential. Investors searching for overlooked growth opportunities should consider industrial biotech BioAmber (NYSE:BIOA), pharmaceutical services company Codexis (NASDAQ:CDXS), and one-trick-pony biopharma Keryx Biopharmaceuticals (NASDAQ:KERX).

Top 10 Clean Energy Stocks To Own Right Now: Amphenol Corporation(APH)

Advisors’ Opinion:

  • [By Darren Williams] Although the entire cannabis space has quietly taken a hit of their own medicine in recent weeks and gone to sleep, don’t think for one second the entire space isn’t going to light up again soon. That’s just what they do, right? However, knowing who the pretenders are and knowing who the contenders are is really the challenge when it’s comes right down to it.
    First, anyone who claims to be a grower or a seller of cannabis can’t for one second ever make it as a public company right now, or can even legally consider being a public company for that matter, so you can scratch any of those right off your list. At least here in the U.S. anyway, because Canada is already well ahead of the curve having legalized it for medicinal purposes already.
    More importantly, full legalization of marijuana in Canada appears to be on track for July 2018, which will make Canada just the second nation in the world after Uruguay to completely legalize the cultivation, sale and possession of the drug for medical and recreational purposes.
    Regardless, the best time to buy any stocks in a hot growth sector is when either everyone has forgotten about them, or when the overall market landscape has turned bearish, which has yet to happen. However, the former seems to be the case for the cannabis space, despite some very favorable state legislation last Fall.
    For now, as long as you have a license issued by Health Canada, you’re good to go, so there are some stocks trading in Canada already who are well on their way to making some green for investors. Canopy Growth Corporation (TSE: WEED), formerly Tweed Marijuana Inc., is a medical marijuana company based in Smiths Falls, Ontario. Aurora Cannabis Inc. (CVE: ACB), which is engaged in the production and sale of medical cannabis. There’s also Aphria Pharmaceutical Company (TSE: APH), which also is engaged in producing and selling medical marijuana through retail sales and wholesale channels.
    There are many more, but those are just a
  • [By Lee Jackson]

    This is the top pick in the sector and has remained a favorite at RBC for some time.Amphenol Corp. (NYSE: APH) is one of the worlds largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors, interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable.

Top 10 Clean Energy Stocks To Own Right Now: Ritchie Bros. Auctioneers Incorporated(RBA)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Raymond James has downgraded Ritchie Bros. Auctioneers Inc (USA) (NYSE: RBA) common stock to Market Perform

    Loop Capital's Betsy Van Hees sees storage, networking, and connectivity as the 3 reasons why Marvell Technology Group Ltd. (NASDAQ: MRVL) will return to top-Line growth. She reiterated her Buy rating and $18 price target. 

  • [By Max Byerly]

    Ritchie Bros. Auctioneers Inc (NYSE:RBA) (TSE:RBA) – Analysts at Jefferies Group boosted their Q2 2018 earnings estimates for Ritchie Bros. Auctioneers in a report issued on Monday, April 9th. Jefferies Group analyst S. Volkmann now expects that the business services provider will earn $0.39 per share for the quarter, up from their prior forecast of $0.37. Jefferies Group has a “Hold” rating and a $30.00 price target on the stock. Jefferies Group also issued estimates for Ritchie Bros. Auctioneers’ Q3 2018 earnings at $0.16 EPS.

Top 10 Clean Energy Stocks To Own Right Now: Dermira, Inc.(DERM)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Current market dynamics, particularly in the SMID biotech universe, provide a plethora of opportunities for the company to augment the breadth and depth its pipeline in its core therapeutic areas, including neurology, ophthalmology and dermatology, where innovation is rife and where consolidation of some of the smaller players in the space is likely, in our view. Stocks in our SMID coverage universe that could potentially constitute future acquisition targets forAllergan include Aclaris Therapeutics (ACRS) and Dermira (DERM) (both have mid- to late-stage dermatology assets in development). We note with interest the collaboration with Heptares announced yesterday evening for the development of several M1, M4 and dual M1/M4 agonists in development for a variety of neurological diseases, including Alzheimers disease. Notwithstanding this above, larger scale transactions of course cannot be ruled out, and we note todays market commentary (Fox Business) regarding the potential sale of Valeant Pharmaceuticals International’s (VRX) Bausch & Lomb unit. It is reasonable to assume thatAllergan could be a bidder for this asset, given the companys presence in ophthalmology, as well as CEO Brent Saunders familiarity with the asset (he was the CEO prior to its sale toValeant in 2013 for $8.7bn). At the time of its sale to Valeant, B&L was generating c.$3bn in revenues and growing at a double-digit rate. Current sales of the asset are unclear due to the reporting structure of Valeant, as well as concerns regarding the companys operating/ pricing strategy.

  • [By WWW.GURUFOCUS.COM]

    For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A

    These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4

  • [By Chris Lange]

    Dermira Inc. (NASDAQ: DERM) watched its shares absolutely collapse early on Monday after the firm reported disappointing results from its late-stage trials in patients with acne vulgaris. Essentially, Dermiras Phase 3 trials of the investigational treatment olumacostat glasaretil (formerly DRM01) did not meet the co-primary endpoints.

Top 10 Clean Energy Stocks To Own Right Now: TiVo Inc.(TIVO)

Advisors’ Opinion:

  • [By Lisa Levin]

    TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 20 percent to $9.22. The New York Times reported that Tivo and Rovi Corporation (NASDAQ: ROVI) are in merger talks.

  • [By Lisa Levin]

    TiVo Inc. (NASDAQ: TIVO) shares were also up, gaining 21 percent to $9.30. The New York Times, citing sources familiar with the issue, said Rovi Corporation (NASDAQ: ROVI) is in advanced negotiations to acquire TiVo. TiVo shareholders would reportedly receive both cash and stock; however, the price tag is yet to be determined.

Top 10 Clean Energy Stocks To Own Right Now: iShares MSCI Europe Financials Sector Index Fund(EUFN)

Advisors’ Opinion:

  • [By Wayne Duggan]

    Investors looking to set up a pair trade to capitalize on the divergent paths of U.S. and European banks should consider going long the iShares Dow Jones US Financial (ETF) (NYSE: IYF) and short the Ishares MSCI Europe Fincls Sctr Indx Fd (NASDAQ: EUFN).

Top 10 Clean Energy Stocks To Own Right Now: Aclaris Therapeutics, Inc.(ACRS)

Advisors’ Opinion:

  • [By Chris Lange]

    Aclaris Therapeutics Inc. (NASDAQ: ACRS) saw its shares make a handy gain on Friday after the company announced the pricing of its secondary offering. The company intends to price its 4 million shares at $22.75 per share, with an overallotment option for an additional 600,000 shares. At this price the entire offering is valued up to $104.65 million.

  • [By Peter Graham]

    Small cap hair loss stocks Aclaris Therapeutics (NASDAQ: ACRS), Cytori Therapeutics (NASDAQ: CYTX) and RepliCel Life Sciences (OTCQB: REPCF; CVE: RP) are trying to tap into a big market as currently, there are only two FDA-approved drugs available for the treatment of Androgenetic Alopecia (AGA) -also known as male or female pattern baldness (one of which cannot be used by women). Thus, a significant unmet need exists for a safe andefficacious product especially since its experienced by 70% of men and 40% of women as they age.

Top 10 Clean Energy Stocks To Own Right Now: Nord Anglia Education, Inc.(NORD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Nord Anglia Education Inc (NASDAQ: NORD) shares shot up 19 percent to $32.83 after the company agreed to be acquired for $32.50 per share in cash.

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested going long on small cap international school stock Nord Anglia Education Inc (NYSE: NORD):

Top 10 Clean Energy Stocks To Own Right Now: Great Canadian Gaming Corporation (GCGMF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Clairvest Group previously initiated an investment in a partnership that involved Great Canadian Gaming Corporation (OTCPK:GCGMF) and Brookfield Business Partners LP to operate two casinos in Southern Ontario. With this announcement, we not only get the upside of a 45% ownership of “Ontario Gaming West GLA Limited Partnership,” which includes four major operations, but also 2,500 slot machines, 60 table games, racing track and $450 million in gross gaming revenue. Clairvest has a history in the gambling industry and Great Canadian Gaming Corporation is a proven operator with a terrific track record.

  • [By SEEKINGALPHA.COM]

    SA: You recently published a thesis on Great Canadian Gaming (OTCPK:GCGMF), a Canadian company do you see the Canadian (or another) market as having greater opportunity to uncover hidden value than the U.S.?

Top 10 Clean Energy Stocks To Own Right Now: Rick’s Cabaret International Inc.(RICK)

Advisors’ Opinion:

  • [By Peter Graham]

    After the market closed yesterday, small cap restaurant and entertainment stockDave & Busters Entertainment Inc (NASDAQ: PLAY) reported Q4 2016 earnings with shares falling by mid single digit percentagesin after hours trading. The Company apparently beat expectations on earnings, but fell short of expectations for comps. Likewise, the stock has already had a very good run meaning expectations were super high.Take a look at the following long term chart which shows Dave & Busters Entertainmentsshare performanceascompared to potential peers such as Buffalo Wild Wings (NASDAQ: BWLD) and upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK):

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment being a pretty steady performer up until June while potential peer, upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK), took off last yearand Buffalo Wild Wings (NASDAQ: BWLD) has started to fall off:

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment doubling in valuewhile potential peer, small cap upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK), began to takeoff last yearand small capBuffalo Wild Wings (NASDAQ: BWLD) has basically been range bound for the last four days:

best stock for investment

Over the last few months, we have reiterated a few times that we believe that today’s market is risky. Valuations are expensive and political and economic risks are high. This situation requires extreme care and scrutiny into current and future positions. Unfortunately, not many stocks or industries are at fair value.

One of the few sectors that has the potential to offer returns, in our opinion, is the pharmaceutical sector. Political claims sent pharma stocks into a tailspin. Both Clinton and elected President Trump repeatedly campaigned that they wanted to lower drug prices. In a recent Time interview, Trump said “I am going to bring down drug prices I don’t like what’s happened with drug prices.” Do we know how he is going to do that? Obviously not.

Trump says and tweets about a lot of things. It is difficult to speculate about what exactly will happen, but it is well known that politicians attract votes with promises they already know they can’t maintain. A recent example is the Brexit campaign (many associated Trump with Brexit). Farage was the main promoter of Brexit. The leave campaign argued that leaving the EU would provide 拢350M/week in savings that could be redirected to the national health system.

best stock for investment: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than

best stock for investment: Great Canadian Gaming Corporation (GCGMF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Clairvest Group previously initiated an investment in a partnership that involved Great Canadian Gaming Corporation (OTCPK:GCGMF) and Brookfield Business Partners LP to operate two casinos in Southern Ontario. With this announcement, we not only get the upside of a 45% ownership of “Ontario Gaming West GLA Limited Partnership,” which includes four major operations, but also 2,500 slot machines, 60 table games, racing track and $450 million in gross gaming revenue. Clairvest has a history in the gambling industry and Great Canadian Gaming Corporation is a proven operator with a terrific track record.

  • [By SEEKINGALPHA.COM]

    SA: You recently published a thesis on Great Canadian Gaming (OTCPK:GCGMF), a Canadian company do you see the Canadian (or another) market as having greater opportunity to uncover hidden value than the U.S.?

best stock for investment: Boeing Company (The)(BA)

Advisors’ Opinion:

  • [By Paul Ausick]

    The Boeing Co. (NYSE: BA) traded up 1.59% at $240.95. The stock’s 52-week range is $126.31 to $246.49. Volume was about 20% below the daily average of around 3.4 million. The company had no specific news Monday, but the North Korean missile launch gave defense stocks, including UTC a boost in today’s trading.

  • [By Paul Ausick]

    There were two big winners in 2017 and three more stocks that posted very solid gains above 40%:

    Boeing Co. (NYSE: BA), up 89% Caterpillar Inc. (NYSE: CAT), up 68.9% Visa Inc. (NYSE: V), up 46.1% Apple Inc. (NASDAQ: AAPL), up 46.1% Wal-Mart Stores Inc. (NYSE: WMT), up 42.9%.

    A stronger global economy contributed to the fortunes of at least two of these firms. while lower U.S. unemployment and improving wages helped the more consumer oriented companies post their gains.

  • [By Paul Ausick]

    The Boeing Co. (NYSE: BA) traded up 2.83% at $291.18. The stock’s 52-week range is $9153.06 to $292.80. The high was posted this morning. Volume was about 20% higher than the daily average of around 3.2 million shares. The company raised its dividend and launched a new $14 billion share buyback program.

best stock for investment: Internap Network Services Corporation(INAP)

Advisors’ Opinion:

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

  • [By Lisa Levin]

    Shares of Internap Corp (NASDAQ: INAP) got a boost, shooting up 13 percent to $2.97 on strong quarterly results. Stifel Nicolaus upgraded Internap from Hold to Buy and raised the price target from $2.00 to $5.50.

  • [By Lisa Levin]

    Shares of Internap Corp (NASDAQ: INAP) got a boost, shooting up 28 percent to $2.32 as the company reported that it has raised $43 million in a common equity private placement.

best stock for investment: Eagle Materials Inc(EXP)

Advisors’ Opinion:

  • [By David Sterman]

    Of course, in many cyclical industries, it’s impossible to maintain very strong growth rates when the economy slumps. And that was a lesson learned by Eagle Materials (NYSE: EXP(link is external)), a maker of drywall, cement and other materials used in homebuilding. Eagle experienced solid growth a decade ago, but when the housing market tanked, so did Eagle’s revenue base. Sales fell by half from fiscal 2007 through fiscal 2011 (to around $460 million).

    Yet even before the pace of home construction returns to normal levels, Eagle is again experiencing solid growth: Sales are now growing at a 30% pace and are expected to surpass $1.1 billion in the current fiscal year, which began this month. That’s 25% higher than the peak in fiscal 2007, and it’s setting the stage for solid profit growth: Earnings per share (EPS) are growing at a 50% pace these days, a pace which could be sustained for an extended period if the housing market finally starts to grow at a solid clip. 

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 1.10 percent. Meanwhile, top losers in the sector included Mechel PAO (ADR) (NYSE: MTL), down 8 percent, and Eagle Materials, Inc. (NYSE: EXP), down 6 percent.

  • [By Maxx Chatsko]

    Shares of construction materials leader Eagle Materials (NYSE:EXP) set new all-time highs earlier this year, although the stock’s recent surge was catalyzed by the announcement of fiscal second-quarter 2017 results in late October. At the time, the company set record revenues and more than doubled earnings per share from the prior-year period. That was followed by a new high watermark for quarterly sales in the fiscal third quarter of 2017, which ended in December, marking the third consecutive quarter in which record revenue was established.

best stock for investment: Daiichi Sankyo Company, Limited (DSKYF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    According to Bob Radie (see transcript of January 9th teleconference), the company’s president and chief executive officer, a key consideration in the denial was the FDA’s granting, in November 2016, rival product MorphaBond three-year exclusivity for the intranasal route of abuse. Significantly, though, even though MorphaBond – developed by tiny, privately-owned Inspirion Delivery Technologies – was approved in October 2015, it is yet to be commercialized. An October 25, 2016, marketing agreement between Inspirion and Japan-based Daiichi Sankyo, Inc. (OTCPK:DSKYF) suggests MorphaBond could be launched in the near future, but it’s also important to note that the aforementioned exclusivity expires on October 2, 2018, at which point Egalet will be able to include the clinical data from its intranasal abuse potential study in its label.